Assertio (ASRT)
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an o...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 23.500
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 23.500
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Assertio Analyst Rating
View moreForecast & Rating
May 13, 2026Price forecast
$24.433.97%
Forecast & RatingHold
4analysts
- Strong buy25.00%
- Buy0.00%
- Hold75.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · Jun 16 at 03:53 PM
Assertio Holdings Announced Transfer or Voluntary Withdrawal of Listing
- TradingView · Jun 16 at 03:53 PM
Assertio directors Ravi Yadavar and Punit Patel join board as six directors resign
- TradingView · Jun 16 at 03:53 PM
Assertio Amends 2027 Convertible Notes After Merger; Holders Get Cash-Only Conversion, Put Right
- StockTitan · Jun 16 at 07:30 AM
Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027 | ASRT Stock News
- PR Newswire · Jun 9 at 12:19 PM
Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?
- PR Newswire · May 25 at 03:13 PM
Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?
